A veteran medical professional and leading figure in healthcare public policy, Dr. Scott Gottlieb brings 20 years of experience in healthcare to his position as a resident fellow at the American Enterprise Institute. One of the nation’s leading think tanks, AEI devotes its research to promoting innovation, private enterprise and individual liberties. In his role with AEI, Dr. Scott Gottlieb helps drive the national conversation about ways to improve the organization and delivery of medical care through his research and frequent writings. In addition to his work with the American Enterprise Institute, Dr. Scott Gottlieb is a clinical assistant professor of medicine at the New York University School of Medicine in New York. Dr. Gottlieb is also a venture partner at the venture capital firm New Enterprise Associates and advises T.R. Winston, a merchant bank focused on healthcare and other growth industries. Scott Gottlieb serves on the policy boards of the Leukemia and Lymphoma Society and the Society of Hospitalist Medicine. Dr. Gottlieb is also an adviser to the National Comprehensive Cancer Network and a member of Cancer Commons. Dr. Scott Gottlieb was appointed by the Senate to serve as a member of the Federal Healthcare IT Policy Committee, which makes recommendations to the Department of Health and Human Services. Dr. Gottlieb testifies frequently before Senate and House committees on issues related to healthcare, medical policy, and regulation. Dr. Scott Gottlieb also remains active in the capital markets related to healthcare, and serves as a director to several life science and healthcare services companies and as a member of the Product Investment Board of GlaxoSmithKline and a Senior Advisor to Vertex Pharmaceuticals. Scott Gottlieb received his undergraduate degree in Economics at Wesleyan University, in Middletown, Connecticut. Dr. Gottlieb went on to complete his medical degree and residency training at the Mount Sinai School of Medicine and the Mount Sinai Medical Center in New York City. Dr. Gottlieb has worked on the editorial staffs of the British Medical Journal and the Journal of the American Medical Association, and as a consultant to ABC News. He writes regular features for the Wall Street Journal editorial page and is a columnist at Forbes.com


Mount Sinai Hospital

Residency in Internal Medicine

June 1999 - June 2002

Mount Sinai School of Medicine

Medical Degree

Jan 1995 - Jan 1999 | New York, NY

Wesleyan University

Bachelor of Arts in Economics

Sep 1990 - May 1994 | Middletown, CT


American Enterprise Institute

Resident Fellow

Jan 2007 - Jan 2012 | Washington, DC

Research and write on issues related to the intersection of clinical medicine, healthcare innovation, and private enrepreneurship. 

Food and Drug Administration

Deputy Commissioner for Medical and Scientific Affairs

Aug 2005 - Feb 2007 | Rockville, MD

Appointed by the President of the United States to serve as the agency's deputy commissioner for medical and scientific affairs

New Enterprise Associates

Venture Partner

Sep 2007 - Present | Chevy Chase, MD


Member, Product Investment Board

Sep 2010 - Present | Philadelphia, PA

New York University School of Medicine

Clinical Assistant Professor of Medicine

Jan 2012 - Present | New York, NY

Alex. Brown & Sons


June 1994 - Sep 1995 | Baltimore, MD

Financial Analyst for this leading investment bank that was focused on financing the development of high growth companies in the 1990s

Vertex Pharmaceuticals

Senior Advisor

Jan 2010 - Present | Boston, MA

Federal Healthcare IT Policy Committee

Committee Member

Sep 2013 - Present | Washington, DC

New Section

Scott Gottlieb's Blog Can Be Found At Forbes.com

A more complete selection of Scott Gottlieb's written work is found at WWSG. Dr. Gottlieb's media appearances can be found at AEI.

You can find Dr. Scott Gottlieb's profile on LinkedIn.

An Interview with Scott Gottlieb.